Nobilis Therapeutics
Hospital & Health Care, 111 Sw 5th Ave, Portland, Oregon, 97204, United States, 11-50 Employees
Phone Number: 97********
Who is NOBILIS THERAPEUTICS
Nobilis Therapeutics, Inc. is a Delaware C-corporation that is focused on therapeutic uses of inert gas mixtures and development of portable devices for their self-administration. Founded...
Read More
-
Headquarters: 111 Sw 5th Ave, Portland, Oregon, 97204, United States
-
Date Founded: 2016
-
Employees: 11-50
-
Revenue: $10 Million to $25 Million
-
Active Tech Stack: See technologies
Industry: Hospital & Health Care
SIC Code: 2899
Does something look wrong? Fix it. | View contact records from NOBILIS THERAPEUTICS
Nobilis Therapeutics Org Chart and Mapping
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Nobilis Therapeutics
Answer: Nobilis Therapeutics's headquarters are located at 111 Sw 5th Ave, Portland, Oregon, 97204, United States
Answer: Nobilis Therapeutics's phone number is 97********
Answer: Nobilis Therapeutics's official website is https://nobilistx.com
Answer: Nobilis Therapeutics's revenue is $10 Million to $25 Million
Answer: Nobilis Therapeutics's SIC: 2899
Answer: Nobilis Therapeutics has 11-50 employees
Answer: Nobilis Therapeutics is in Hospital & Health Care
Answer: Nobilis Therapeutics contact info: Phone number: 97******** Website: https://nobilistx.com
Answer: Nobilis Therapeutics, Inc. is a Delaware C-corporation that is focused on therapeutic uses of inert gas mixtures and development of portable devices for their self-administration. Founded by a drug developer, a scientist and a pioneer of medical gas research, the Company has been able to capture the field and in a very short time has accomplished a tremendous amount. Nobilis Therapeutics has entered into an exclusive licensing agreement with Harvard University on the use of NBTX-001 to treat PTSD, filed 10 patents, and is well positioned to initiate 2 clinical trials in the coming months. The Company has been able to attract a premier team of key opinion leaders to its scientific advisory board (link to SAB section) that have become instrumental in guiding its clinical development strategy. Nobilis Therapeutics has completed the design of an inhalational device that will be used for its PTSD clinical trial at Harvard University and is actively working on the development of ZephyrusTM, a portable hand-held device for self-administration of NBTX-001.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month